Important information regarding the contacts and business relationships that you make through the B2B MARKET PLACE, keep in mind that:

  1. PROCOLOMBIA accompanies companies with the purpose of facilitating business opportunities between exporters and buyers, without intervening in purchase and/or sale decisions, therefore, the contractual and legal responsibility of commercial negotiations falls directly on the companies that carried out the commercial transaction (exporter and buyer).
  2. Although PROCOLOMBIA carries out a preliminary investigation of the companies as part of its work methodology and commercial management, this process does not constitute any guarantee of compliance in the negotiations between the parties, for this reason it is recommended that both the exporter and the buyer carry out their own validations and protect their commercial operations with the mechanisms available in international trade regulations.
  3. The relationship between PROCOLOMBIA and the companies in Colombia and abroad, is generated through trust and the experience acquired from previous actions; however, such companies may present situations that could lead to possible breaches, without these being the responsibility of PROCOLOMBIA, which is why both exporters and buyers must ensure that they use secure negotiation tools, seek advice from experts to assess commercial risks and formalize the contractual documents that may be necessary to shield their conversations.
  4. ProColombia will in no case be responsible for the information of the companies and/or products available on this platform since it is filled out completely by each one of the companies.
Icon
Description

With a growing pharmaceutical company and manufacturing industry, a well established healthcare system, and sustainable investment on health research, Colombia continues to be an attractive place for investors and international companies to put their bet on the country.

What positions Colombia as one of the best pharma manufacturers in Latin America is its biodiversity, flexible trade agreements allowing the country to be a great exportation hub and access to innovative technology.

The country’s rich biodiversity offers great opportunity to develop natural products attracting more global companies.

The local production of generic drugs, over-the-counter pharmaceutical products and patent medicines has created a great potential to attract new global markets and multinational companies.

In 2015, pharmaceutical and chemical supplier companies in Colombia exported goods that were worth $525.4 million U.S dollars.
Pharmacy laboratories and pharmaceutical companies in Colombia are well equipped in terms of technology to meet the quality and production standards needed to deliver the best high end pharmacy supplies.

Bogota, the capital of Colombia, holds most of the country’s market with 66% of pharma manufacturers producing pharmaceutical products and where 65% are wholesalers distributors. The city is responsible for 47% of all exportation becoming an important hub to develop chemical synthesis medicines.

The main export destinations are Ecuador, Venezuela, Peru, Panama and the United States.

It is expected for the Colombian pharmaceutical market to grow at a rate of around 7.3 percent and reach a USD 7.1 billion valuation by 2020.
There is no doubt that Colombia offers a great deal for regional production and distribution hubs for pharmaceutical products.

 

Image
Farmacéuticos
Subscribe to Pharmaceuticals

Splend Colirio

Splend Colirio Image
Splend Colirio Image
Otic-ophthalmic solution indicated for the control and treatment of otitis, purulent inflammation of the ear and eye infections in dogs and cats. SPLEND EYE DROPS®, is indicated in inflammatory and infectious processes such as blepharitis, conjunctivitis, keratitis, and external and middle otitis.

Icofarma S.A.

Web
https://icofarma.com/
The Company, Industria Colombiana Farmacéutica ICOFARMA S.A., is dedicated to develop, manufacture and market, nationally and internationally, veterinary pharmaceutical drugs and, at the national level, human medicines and functional foods. All of the above, under high quality standards.

Ungüento No. 100

Ungüento No. 100 Image
Antiphlogistic, anti-inflammatory and rubefacient External use

ERMASID

ERMASID Image
Oral suspension Treatment of diarrhea, ulcer and gastritis

FLUVIPEN L.A. | 3 MILL

FLUVIPEN L.A. | 3 MILL Image
Long-acting antibiotic with anti-inflammatory.

XILACINA 2%

XILACINA 2% Image
Sedative, analgesic and muscle relaxant. 2% injectable solution

ALAPIEL

ALAPIEL Image
Dermatological cream. antibacterial, antifungal, anti-inflammatory and healing.

Laboratorios Erma SA

Web
https://www.laboratorioserma.com/
Laboratorios Erma is a pioneer company in the Colombian veterinary pharmaceutical market, it has the experience of more than 76 years in the manufacture of veterinary medicines and thanks to the knowledge, wisdom and expertise acquired in all that time, it recently inaugurated a modern pharmaceutical manufacturing plant, built in an area of ​​6000 square meters and endorsed by the Colombian Agricultural Institute ICA and certified in Good Manufacturing Practices according to the standards required by the World Health Organization. Know-how and the tradition of successful products in the market and recognized in several Latin American countries constitute the best letter of introduction for a company that values ​​the quality of its products and the warmth of its staff. In Erma Laboratories there is "Experience in Quality".

DOXIFIG

DOXIFIG Image
Indicated for the treatment of diseases such as: Bartonellosis, pneumonias and bronchopneumonia, pharyngitis, tracheitis, tonsillitis, otitis, bronchitis and sinusitis, genitourinary infections: metritis and cystitis, leptospirosis, borreliosis (lyme disease), Erlichiosis, toxoplasmosis, tetanus, brucellosis, gastrointestinal infections and diarrhea, otitis, deep and superficial pyoderma, abscesses, boils, cellulitis, prevention of infections in post-operative or treatment of infected wounds, joint infections, periostitis, gingivitis, osteoarthritis.

Kelfar

Kelfar Image
Kelfar Image
KELFAR (CHELATING AGENT IN SYRINGE)
Effective chelating and lubricating agent in cream, facilitates the removal of the superficial layer of dentin.
Produces a whitening action on the tooth, appropriate for endodontic treatment.
https://www.eufar.com/KELFAR-Quelante-ensanchadorJERINGA-5g
Subscribe to Pharmaceuticals